News about "Revive Therapeutics gets US FDA recommendation tos"

Revive Therapeutics gets US FDA recommendation tostart phase 3 trial of Bucillamine to treat COVID-19

Revive Therapeutics gets US FDA recommendation tostart phase 3 trial of Bucillamine to treat COVID-19

Revive Therapeutics, a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has received positive feedback from the US Food and Drug Administration (FDA) in response to the company's Pre-Investigational New Drug (pre-IND) meeting

Revive Therapeutics Gets US FDA Recommendation Tos | 25/04/2020 | By Darshana 816


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members